Monday, 23 September 2019

SpeeDx distribution network expands to the Middle East

18 March 2019 | News

Al Zahrawi Medical Supplies will be the new distributor for Gulf Cooperation Council

SpeeDx has announced signing new partners Al Zahrawi Medical Supplies LLC for distribution of ResistancePlus® and PlexPCR® tests across UAE, Saudi Arabia, Oman, Bahrain, and Qatar.

Colin Denver, SpeeDx CEO said, “Al Zahrawi Medical are the leading medical and diagnostic suppliers in the region and will be the perfect partner to expand our business into the GCC. Our products address the global issues of antibiotic resistance and reproductive health. With this deal we are pleased that even more laboratories will now be able to access our ResistancePlus tests for Mycoplasma genitalium and gonorrhoea to bring Resistance Guided Therapy to patients worldwide.”

The SpeeDx ResistancePlus tests provide information, combining detection of infection with genetic markers linked to antibiotic resistance – empowering clinicians to make informed treatment decisions. Resistance Guided Therapy has been heralded as a major breakthrough for the management of bacterial infections, providing information to treating clinicians on the infection’s susceptibility or resistance status to common frontline antibiotics, improving cure rates, and reducing overall health costs.

ResistancePlus GC combines Neisseria gonorrhoeae (GC) detection with markers for ciprofloxacin susceptibility, ResistancePlus MG simultaneously detects Mycoplasma genitalium and genetic markers for azithromycin resistance.

SpeeDx also plans to release a new ResistancePlus MG test for resistance markers linked to second-line antibiotic treatment failure, as well as a ResistancePlus MP test for Mycoplasma pneumoniae and macrolide resistance markers.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls